prof.dr. (Werner) W.B.F. Brouwer

All publications (352)

• Article (290)

  • Scholarly Publication (224)

    • P.H.M. van Baal, A. Morton, D. Meltzer & W.B.F. Brouwer (2018). Future unrelated medical costs need to be considered in cost effectiveness analysis. European Journal of Health Economics (HEPAC). doi: 10.1007/s10198-018-0976-0
    • S.A. Lipman, W.B.F. Brouwer & A.E. Attema (2018). A QALY loss is a QALY loss is a QALY loss: a note on independence of loss aversion from health states. European Journal of Health Economics (HEPAC). doi: 10.1007/s10198-018-1008-9[go to publisher's site]
    • W.B.F. Brouwer, P.H.M. van Baal, N.J.A. van Exel & M.M. Versteegh (2018). When is it too expensive? Cost-effectiveness thresholds and health care decision-making. European Journal of Health Economics (HEPAC). doi: 10.1007/s10198-018-1000-4
    • A.E. Attema, W.B.F. Brouwer & J.L. Pinto-Prades (2018). Peer effects in health valuation: The relation between rating of contemporaries' health and own health. Health and Quality of Life Outcomes, 16:148. doi: 10.1186/s12955-018-0978-8[go to publisher's site]
    • V.T. Reckers, N.J.A. Van Exel & W.B.F. Brouwer (2018). Who should receive treatment? An empirical enquiry into the relationship between societal views and preferences concerning healthcare priority setting. PLoS One (online), 13 (6):e0198761. doi: 10.1371/journal.pone.0198761[go to publisher's site]
    • P.H.M. van Baal, M.S. Perry-Duxbury, P.L.H. Bakx, M.M. Versteegh, E.K.A. van Doorslaer & W.B.F. Brouwer (2018). A cost-effectiveness threshold based on the marginal returns of cardiovascular hospital spending. Health Economics, 2018, 1-14. doi: 10.1002/hec.3831
    • A.E. Attema, W.B.F. Brouwer & K. Claxton (2018). Discounting in economic evaluations. Pharmacoeconomics (Print), 36 (7), 745-758. doi: 10.1007/s40273-018-0672-z[go to publisher's site]
    • V.T. Reckers, N.J.A. Van Exel & W.B.F. Brouwer (2018). Looking back and moving forward: On the application of proportional shortfall in healthcare priority setting in the Netherlands. Health Policy, 122 (6), 621-629. doi: 10.1016/j.healthpol.2018.04.001[go to publisher's site]
    • A.E. Attema, H.M. Krol, N.J.A. van Exel & W.B.F. Brouwer (2018). New findings from the time trade-off for income approach to elicit willingness to pay for a quality adjusted life year. European Journal of Health Economics (HEPAC), 19 (2), 277-291. doi: 10.1007/s10198-017-0883-9
    • F.C.W. van Krugten, M. Goorden, A.J.L.M. van Balkom, J. Spijker, W.B.F. Brouwer & L. Hakkaart-van Roijen (2018). Indicators to facilitate the early identification of patients with major depressive disorder in need of highly specialized care: A concept mapping study. Depression and Anxiety, 35 (4), 346-352. doi: 10.1002/da.22741[go to publisher's site]
    • E.J. van de Wetering, N.J.A. van Exel & W.B.F. Brouwer (2017). The risk of conditional reimbursement: Stopping reimbursement can be more difficult than not starting in the first place! Value in Health, 20 (1), 118-125.
    • S. Wouters, N.J.A. van Exel, R. Baker & W.B.F. Brouwer (2017). Priority to end of life treatments? Views of the public in the Netherlands. Value in Health, 20 (1), 107-117.
    • S.J. Schawo, C.A.M. Bouwmans - Frijters, E. van der Schee, V. Hendriks, W.B.F. Brouwer & L. Hakkaart - van Roijen (2017). The search for relevant outcome measures for cost-utility analysis of systemic family interventions in adolescents with substance use disorder and delinquent behavior: a systematic literature review. Health and Quality of Life Outcomes, 15:179. doi: 10.1186/s12955-017-0722-9
    • M. Gheorghe, S. Picavet, M. Verschuren, W.B.F. Brouwer & P.H.M. van Baal (2017). Health losses at the end of life: a Bayesian mixed beta regression approach. Journal of the Royal Statistical Society. Series A. Statistics in Society, 180 (3), 723-749. doi: 10.1111/rssa.12230[go to publisher's site]
    • F.E. van Nooten, W.B.F. Brouwer, J. van Exel, K. Houghton, M. van Agthoven & D.A. Stull (2017). A (Latent) Class of Their Own: Response Patterns in Trading Off Quantity and Quality of Life in Time Trade-Off Exercises. Value in Health, 20 (10), 1403-1410. doi: http://dx.doi.org/10.1016/j.jval.2017.06.008
    • S.J. Schawo, W.B.F. Brouwer & L. Hakkaart - van Roijen (2017). Clinicians’ Views on Therapeutic Outcomes of Systemic Interventions and on the Ability of the EQ-5D to Capture these Outcomes. Journal of Mental Health Policy and Economics, 20 (3), 131-136.
    • M.Q.N. Hackert, J. van Exel & W.B.F. Brouwer (2017). Valid Outcome Measures in Care for Older People: Comparing the ASCOT and ICECAP-O. Value in Health, 20 (7), 936-944. doi: 10.1016/j.jval.2017.03.012[go to publisher's site]
    • P.H.M. van Baal, A. Morton, D.O. Meltzer & W.B.F. Brouwer (2017). Should cost effectiveness analyses for NICE always consider future unrelated medical costs? BMJ-British medical journal, Nov 10, 359-359. doi: 10.1136/bmj.j5096[go to publisher's site]
    • S. Wouters, N.J.A. van Exel, K.I.M. Rohde, J.J. Vromen & W.B.F. Brouwer (2017). Acceptable health and priority weighting: discussing a reference-level approach using sufficientarian reasoning. Social Science & Medicine, 181 (May), 158-167. doi: http://dx.doi.org/10.1016/j.socscimed.2017.03.051[go to publisher's site]
    • R.J. Hoefman, N.J.A. van Exel & W.B.F. Brouwer (2017). Measuring care-related quality of life of caregivers for use in economic evaluations: CarerQol tariffs for Australia, Germany, Sweden, the UK and the US. Pharmacoeconomics (Print), 35 (4), 469-478. doi: 10.1007/s40273-016-0477-x[go to publisher's site]
    • D.R. Rappange, N.J.A. van Exel & W.B.F. Brouwer (2017). A short note on measuring subjective life expectancy: Survival probabilities versus point estimates. The European Journal Of Health Economics, 18 (1), 7-12.
    • F. Van Nooten, K. Houghton, J. van Exel, M. van Agthoven, W.B.F. Brouwer & D. Stull (2017). A (latent) class of their own: Response patterns in trading-off quantity and quality of life in TTO exercises. Value in Health, 20 (10), 1403-1410.
    • M.M. Versteegh, S. Knies & W.B.F. Brouwer (2016). From Good to Better: New Dutch Guidelines for Economic Evaluations in Healthcare. Pharmacoeconomics (Print), 34 (11), 1071-1074. doi: http://dx.doi.org/10.1007/s40273-016-0431-y[go to publisher's site]
    • P.H.M. van Baal, D. Meltzer & W.B.F. Brouwer (2016). Future costs, fixed healthcare budgets and the decision rules of cost-effectiveness analysis. Health Economics, 25 (2), 237-248. doi: http://dx.doi.org/10.1002/hec.3138[go to publisher's site]
    • E.J. van de Wetering, N.J.A. van Exel, J.M. Rose, R.J. Hoefman & W.B.F. Brouwer (2016). Are some QALYs more equal than others? European Journal of Health Economics (HEPAC), 17 (2), 117-127. doi: 10.1007/s10198-014-0657-6[go to publisher's site]
    • H.M. Krol, J. Papenburg, S.S. Tan, W.B.F. Brouwer & L. Hakkaart-van Roijen (2016). A Noticeable Difference? Productivity costs related to paid and unpaid work in economic evaluations on expensive drugs. European Journal of Health Economics (HEPAC), 17 (4), 391-402. doi: http://dx.doi.org/10.1007/s10198-015-0685-x[go to publisher's site]
    • H. Mason, N.J.A. van Exel, R. Baker, W.B.F. Brouwer & C. Donaldson (2016). From representing views to representativeness of views: Illustrating a new (Q2S) approach in the context of health care priority setting in nine European countries. Social Science & Medicine, 166, 205-213. doi: 10.1016/j.socscimed.2016.08.036
    • E.J. van de Wetering, N.J.A. van Exel & W.B.F. Brouwer (2016). Health or Happiness? A note on the relative value of health and happiness in rationing decisions. Value in Health, 19 (5), 552-557. doi: http://dx.doi.org/10.1016/j.jval.2016.02.003[go to publisher's site]
    • D.R. Rappange, W.B.F. Brouwer & N.J.A. van Exel (2016). Rational expectations? An explorative study of subjective survival probabilities and lifestyle across Europe. Health Expectations, 19 (1), 121-137. doi: 10.1111/hex.12335
    • F.E. van Nooten, N.J.A. van Exel, D. Eriksson & W.B.F. Brouwer (2016). “Back to the future”: Influence of beliefs regarding the future on TTO answers. Health and Quality of Life Outcomes, 14, 4. doi: http://dx.doi.org/10.1186/s12955-015-0402-6[go to publisher's site]
    • P.P. Barros, W.B.F. Brouwer, S. Thomson & M. Varkevisser (2016). Competition among health care providers: helpful or harmful? European Journal of Health Economics (HEPAC), 17 (3), 229-233. doi: http://dx.doi.org/10.1007/s10198-015-0736-3[go to publisher's site]
    • M.M. Versteegh & W.B.F. Brouwer (2016). Patient and general public preferences for health states: A call to reconsider current guidelines. Social Science & Medicine, 165, 66-74. doi: http://dx.doi.org/10.1016/j.socscimed.2016.07.043[go to publisher's site]
    • A. Morton, A.L. Adler, D. Bell, A. Briggs, W.B.F. Brouwer, K. Claxton, N. Craig, A. Fischer, P. McGregor & P.H.M. van Baal (2016). Unrelated Future Costs and Unrelated Future Benefits: Reflections on NICE Guide to the Methods of Technology Appraisal. Health Economics, 25 (8), 933-938. doi: 10.1002/hec.3366[go to publisher's site]
    • A.E. Attema, W.B.F. Brouwer, O. l'Haridon & J.L. Pinto-Prades (2016). An elicitation of utility for quality of life under prospect theory. Journal of Health Economics, 48, 121-134. doi: http://dx.doi.org/10.1016/j.jhealeco.2016.04.002[go to publisher's site]
    • P. Wubulihasimu, W.B.F. Brouwer & P.H.M. van Baal (2016). The Impact of Hospital Payment Schemes on Healthcare and Mortality: Evidence from Hospital Payment Reforms in OECD Countries. Health Economics, 25 (8), 1005-1019. doi: http://dx.doi.org/10.1002/hec.3205[go to publisher's site]
    • C.J. Tilling, H.M. Krol, A.E. Attema, A. Tsuchiya, J. Brazier, N.J.A. van Exel & W.B.F. Brouwer (2016). Exploring a new method for deriving the monetary value of a QALY. European Journal of Health Economics (HEPAC), 17 (7), 801-809. doi: 10.1007/s10198-015-0722-9[go to publisher's site]
    • D.R. Rappange, W.B.F. Brouwer & N.J.A. van Exel (2016). A long life in good health: Subjective expectations regarding length and future health-related quality of life. European Journal of Health Economics (HEPAC), 17 (5), 577-589. doi: 10.1007/s10198-015-0701-1[go to publisher's site]
    • H.M. Krol, A.E. Attema, N.J.A. van Exel & W.B.F. Brouwer (2016). Altruistic preferences in TTO: Consideration of effects on others in health state valuations. Medical Decision Making, 36 (2), 187-198. doi: 10.1177/0272989X15615870
    • H. Al-Janabi, N.J.A. van Exel, W.B.F. Brouwer, C. Trotter, L. Glennie, L. Hannigan & J. Coast (2016). Measuring health spillovers for economic evaluation: A case study in meningitis. Health Economics, 25 (12), 1529-1544. doi: 10.1002/hec.3259[go to publisher's site]
    • H. Al-Janabi, N.J.A. van Exel, W.B.F. Brouwer, C. Trotter, L. Glennie, L. Hannigan & J. Coast (2016). A framework for including health spillovers in economic evaluation. Medical Decision Making, 36 (2), 176-186. doi: http://dx.doi.org/10.1177/0272989X15605094[go to publisher's site]
    • N.J.A. van Exel, R. Baker, H. Mason, C. Donaldson & W.B.F. Brouwer (2015). Public views on principles for health care priority setting: Findings of a European cross-country study using Q methodology. Social Science & Medicine, 126, 128-137. doi: 10.1016/j.socscimed.2014.12.023
    • M. Gheorghe, W.B.F. Brouwer & P.H.M. van Baal (2015). Did the health of the Dutch population improve between 2001 and 2008? Investigating age- and gender-specific trends in quality of life. European Journal of Health Economics (HEPAC), 16 (8), 801-811. doi: 10.1007/s10198-014-0630-4
    • S. Wouters, N.J.A. van Exel, K.I.M. Rohde & W.B.F. Brouwer (2015). Are all health gains equally important? An exploration of acceptable health as reference point in health care priority setting. Health and Quality of Life Outcomes, 13, 79. doi: 10.1186/s12955-015-0277-6
    • F.E. van Nooten, N.J.A. van Exel, A.H.E. Koolman & W.B.F. Brouwer (2015). “Married with children”: The influence of significant others in TTO exercises. Health and Quality of Life Outcomes, 13 (94). doi: http://dx.doi.org/10.1186/s12955-015-0276-7[go to publisher's site]
    • E. Vermaire, C. van Loveren, W.B.F. Brouwer & M. Krol (2015). Een economische evaluatie van twee verschillende cariëspreventieve strategieën vergeleken met standaard zorg. Nederlands Tijdschrift voor Tandheelkunde (NTVT), 122, 393-401. doi: 10.5177/ntvt.2015.07/08.15144
    • E.J. van de Wetering, N.J.A. van Exel, A. Bobinac & W.B.F. Brouwer (2015). Valuing QALYs in Relation to Equity Considerations Using a Discrete Choice Experiment. Pharmacoeconomics (Print), 33, 1289-1300. doi: 10.1007/s40273-015-0311-x
    • S. Wouters, N.J.A. van Exel, M. van den Donk, K.I.M. Rohde & W.B.F. Brouwer (2015). Do people desire to be healthier than other people? A short note on positional concerns for health. The European Journal Of Health Economics, 16 (1), 47-54. doi: http://dx.doi.org/10.1007/s10198-013-0550-8
    • J.M. Tilford, N. Payakachat, K.A. Kuhlthau, J.M. Pyne, E. Kovacs, J. Bellando, D.K. Williams, W.B.F. Brouwer & R.E. Frye (2015). Treatment for Sleep Problems in Children with Autism and Caregiver Spillover Effects. Journal of Autism and Developmental Disorders, 45 (11), 3613-3623. doi: 10.1007/s10803-015-2507-5[go to publisher's site]
    • A.E. Attema, W.B.F. Brouwer, O. l'Haridon & J.L. Pinto-Prades (2015). Estimating sign-dependent societal preferences for quality of life. Journal of Health Economics, 43, 229-243. doi: http://dx.doi.org/10.1016/j.jhealeco.2015.07.006[go to publisher's site]
    • M. Pennington, R. Baker, W.B.F. Brouwer, H. Mason, D. Gyrd Hansen, A. Robinson & C. Donaldson (2015). Comparing WTP values of different types of QALY gain elicited from the general public. Health Economics, 24 (3), 280-293. doi: 10.1002/hec.3018
    • M. Gheorghe, W.B.F. Brouwer & P.H.M. van Baal (2015). Quality of life and time to death: have the health gains of preventive interventions been underestimated? Medical Decision Making, 35 (3), 316-327. doi: 10.1177/0272989X14555771
    • H.M. Krol & W.B.F. Brouwer (2015). Unpaid work in economic evaluations. Social Science & Medicine, 144, 127-137. doi: 10.1016/j.socscimed.2015.09.008
    • H. Kraijo, N.J.A. van Exel & W.B.F. Brouwer (2015). The perseverance time of informal carers for people with dementia: results of a two-year longitudinal follow-up study. BMC Nursing, 14, 56. doi: 10.1186/s12912-015-0107-5
    • C.A. de Uyl-de Groot, W.B.F. Brouwer, J.M. de Maeseneer & J. Verweij (2015). Primary care in cancer control: towards mature cancer care. Lancet Oncology, 16 (22), 1226-1227. doi: http://dx.doi.org/http://dx.doi.org/10.1016/S1470-2045(15)00294-6[go to publisher's site]
    • P. Wubulihasimu, W.B.F. Brouwer & P.H.M. van Baal (2015). Does living longer in good health facilitate longer working lives? The relationship between disability and working lives. European Journal of Public Health, 25 (5), 791-795. doi: 10.1093/eurpub/ckv062.
    • C.A.M. Boumans, H.M. Krol, J.L. Severens, M.A. Koopmanschap, W.B.F. Brouwer & L. Hakkaart-van Roijen (2015). The iMTA Productivity Cost Questionnaire A Standardized Instrument for Measuring and Valuing Health-Related Productivity Losses. Value in Health, 18, 753-758. doi: http://dx.doi.org/10.1016/j.jval.2015.05.009[go to publisher's site]
    • M. Péntek, V. Brodszky, A. Gulácsi, O. Hajdú, N.J.A. van Exel, W.B.F. Brouwer & L. Gulácsi (2014). Subjective expectations regarding length and health-related quality of life in Hungary: results from an empirical investigation. Health Expectations, 17 (5), 696-709. doi: 10.1111/j.1369-7625.2012.00797.x
    • F.E. van Nooten, X. Koolman, J.J.V. van Busschbach & W.B.F. Brouwer (2014). Thirty down, only ten to go?! Awareness and influence of a 10-year time frame in TTO. Quality of Life Research, 23 (2), 377-384. doi: http://dx.doi.org/10.1007/s11136-013-0495-5[go to publisher's site]
    • A.E. Attema & W.B.F. Brouwer (2014). Deriving time discounting correction factors for TTO tariffs. Health Economics, 23 (4), 410-425. doi: http://dx.doi.org/10.1002/hec.2921[go to publisher's site]
    • R.J. Hoefman, N.J.A. van Exel, J.M. Rose, E.J. van de Wetering & W.B.F. Brouwer (2014). A discrete choice experiment to obtain a tariff for valuing informal care situations measured with the CarerQol instrument. Medical Decision Making, 34 (1), 84-96. doi: http://dx.doi.org/10.1177/0272989X13492013[go to publisher's site]
    • A.E. Attema, W.B.F. Brouwer & N.J.A. van Exel (2014). Your right arm for a publication in AER? Economic Inquiry, 52 (1), 495-502. doi: http://dx.doi.org/10.1111/ecin.12013[go to publisher's site]
    • H.M. Krol, E.A. Stolk & W.B.F. Brouwer (2014). Predicting productivity based on EQ-5D: an explorative study. The European Journal Of Health Economics, 15 (5), 465-475. doi: http://dx.doi.org/10.1007/s10198-013-0487-y[go to publisher's site]
    • H.M. Krol, E.A. Stolk & W.B.F. Brouwer (2014). Predicting productivity based on EQ-5D: an explorative study. European Journal of Health Economics (HEPAC), 15 (5), 465-475. doi: 10.1007/s10198-013-0487-y
    • E. Vermaire, H.M. Krol, W.B.F. Brouwer & C. van Loveren (2014). Value for money: economic evaluation of two different caries prevention programmes compared with standard care in a randomized controlled trial. Caries Research, 48 (3), 244-253. doi: 10.1159/000356859
    • P. Makai, W.B.F. Brouwer, M.A. Koopmanschap, E.A. Stolk & A.P. Nieboer (2014). Quality of life instruments for economic evaluations in health and social care for older people: A systematic review. Social Science & Medicine, 102, 83-93. doi: http://dx.doi.org/10.1016/j.socscimed.2013.11.050[go to publisher's site]
    • H.M. Krol & W.B.F. Brouwer (2014). How to include productivity costs in economic evaluations. Pharmacoeconomics (Print), 32 (4), 335-344. doi: 10.1007/s40273-013-0056-3
    • A. Bobinac, J. van Exel, F.F.H. Rutten & W.B.F. Brouwer (2014). The value of a QALY: Individual willingness to pay for health gains under risk. Pharmacoeconomics (Print), 32, 75-86. doi: http://dx.doi.org/10.1007/s40273-013-0110-1[go to publisher's site]
    • N. Payakachat, J.M. Tilford, K.A. Kuhlthau, N.J.A. van Exel, E. Kovacs, J. Bellando, J.M. Pyne & W.B.F. Brouwer (2014). Predicting Health Utilities for Children With Autism Spectrum Disorders. Autism Research, 7 (6), 649-663. doi: http://dx.doi.org/10.1002/aur.1409[go to publisher's site]
    • H. Kraijo, W.B.F. Brouwer, R. de Leeuw, G. Schrijvers & N.J.A. van Exel (2014). The perseverance time of informal carers of dementia patients: validation of a new measure to initiate transition of care at home to nursing home care. Journal of Alzheimers Disease, 40 (3), 631-642. doi: http://dx.doi.org/10.3233/JAD-132420
    • P. Makai, F. Beckebans, N.J.A. van Exel & W.B.F. Brouwer (2014). Quality of life of nursing home residents with dementia: validation of the German version of the ICECAP-O. PLoS One (print), 9 (3), e92016. doi: 10.1371/journal.pone.0092016
    • M. Péntek, L. Gulácsi, B. Rojkovich, V. Brodszky, N.J.A. van Exel & W.B.F. Brouwer (2014). Subjective health expectations at biological therapy initiation: a survey of rheumatoid arthritis patients and rheumatologists. The European Journal Of Health Economics, 15 (S1), 83-92. doi: 10.1007/s10198-014-0597-1
    • R.J. Hoefman, J. van Exel & W.B.F. Brouwer (2013). Measuring the impact of caregiving on informal carers: a construct validation study of the CarerQol instrument. Health and Quality of Life Outcomes, 11, 1-13. doi: http://dx.doi.org/10.1186/1477-7525-11-173[go to publisher's site]
    • T.A. Kanters, W.B.F. Brouwer, R.C.J.A. van Vliet, P.H.M. van Baal & J. Polder (2013). A new prevention paradox: The trade-off between reducing incentives for risk selection and increasing the incentives for prevention for health insurers. Social Science & Medicine, 76, 150-158. doi: http://dx.doi.org/10.1016/j.socscimed.2012.10.019[go to publisher's site]
    • A. Bobinac, J. van Exel, F.F.H. Rutten & W.B.F. Brouwer (2013). Valuing QALY gains by applying a societal perspective. Health Economics, 22, 1272-1281. doi: http://dx.doi.org/10.1002/hec.2879[go to publisher's site]
    • L.M. Niëns & W.B.F. Brouwer (2013). Measuring the affordability of medicines: Importance and challenges. Health Policy, 112, 45-52. doi: http://dx.doi.org/10.1016/j.healthpol.2013.05.018[go to publisher's site]
    • R.J. Hoefman, J. van Exel & W.B.F. Brouwer (2013). How to include informal care in economic evaluations. Pharmacoeconomics (Print), 31 (12), 1105-1119. doi: http://dx.doi.org/10.1007/s40273-013-0104-z[go to publisher's site]
    • P. Makai, M.A. Koopmanschap, W.B.F. Brouwer & A.P. Nieboer (2013). A validation of the ICECAP-O in a population of post-hospitalized older people in the Netherlands. Health and Quality of Life Outcomes, 11 (57). doi: http://dx.doi.org/10.1186/1477-7525-11-57[go to publisher's site]
    • A.E. Attema & W.B.F. Brouwer (2013). In search of a preferred preference elicitation method: A test of the internal consistency of choice and matching tasks. Journal of Economic Psychology, 39, 126-140. doi: http://dx.doi.org/10.1016/j.joep.2013.07.009[go to publisher's site]
    • P.H.M. van Baal, D. Meltzer & W.B.F. Brouwer (2013). Pharmacoeconomics Guidelines Should Prescribe Inclusion of Indirect Medical Costs! A Response to Grima et al. Pharmacoeconomics (Print), 31, 369-373. doi: http://dx.doi.org/10.1007/s40273-013-0042-9[go to publisher's site]
    • E.J. van de Wetering, E.A. Stolk, N.J.A. van Exel & W.B.F. Brouwer (2013). Balancing equity and efficiency in the Dutch basis benefits package using the principle of proportional shortfall. The European Journal Of Health Economics, 14, 107-115. doi: http://dx.doi.org/10.1007/s10198-011-0346-7[go to publisher's site]
    • A.E. Attema, M.M. Versteegh, M. Oppe, W.B.F. Brouwer & E.A. Stolk (2013). LEAD TIME TTO: LEADING TO BETTER HEALTH STATE VALUATIONS. Health Economics, 22 (4), 376-392. doi: http://dx.doi.org/10.1002/hec.2804[go to publisher's site]
    • H.M. Krol, W.B.F. Brouwer & F.F.H. Rutten (2013). Productivity costs in economic evaluations: past, present, future. Pharmacoeconomics (Print), 31 (7), 537-549. doi: http://dx.doi.org/10.1007/s40273-013-0056-3[go to publisher's site]
    • T.A. Kanters, A.T. van der Ploeg, W.B.F. Brouwer & L. Hakkaart-van Roijen (2013). The impact of informal care for patients with Pompe disease: An application of the CarerQol instrument. Molecular Genetics and Metabolism, 110 (3), 281-286. doi: 10.1016/j.ymgme.2013.07.020
    • C.A.G. Wolfs, A. Kessels, J.L. Severens, W.B.F. Brouwer, M. de Vugt, F.R.J. Verhey & C.D. Dirksen (2013). Predictive Factors for the Objective Burden of Informal Care in People With Dementia: a systematic review. Alzheimer Disease & Associated Disorders, 26 (3), 197-204. doi: http://dx.doi.org/10.1097/WAD.0b013e31823a6108[go to publisher's site]
    • A.E. Attema, W.B.F. Brouwer & O. l'Haridon (2013). Prospect theory in the health domain: A quantitative assessment. Journal of Health Economics, 32, 1057-1065. doi: http://dx.doi.org/10.1016/j.jhealeco.2013.08.006[go to publisher's site]
    • A. Bobinac, N.J.A. van Exel, F.F.H. Rutten & W.B.F. Brouwer (2012). GET MORE, PAY MORE? An elaborate test of construct validity of willingness to pay per QALY estimates obtained through contingent valuation. Journal of Health Economics, 31, 158-168. doi: http://dx.doi.org/10.1016/j.jhealeco.2011.09.004
    • J.H. Vermaire, N.J.A. van Exel, C. van Loveren & W.B.F. Brouwer (2012). Putting your money where your mouth is: Parents' valuation of good oral health of their children. Social Science & Medicine, 75, 2200-2206. doi: http://dx.doi.org/10.1016/j.socscimed.2012.08.018
    • A. Bobinac, N.J.A. van Exel, F.F.H. Rutten & W.B.F. Brouwer (2012). Inquiry into the Relationship between Equity Weights and the Value of the QALY. Value in Health, 15, 1119-1126. doi: http://dx.doi.org/10.1016/j.jval.2012.07.002
    • S.J. Schawo, H. van Eeren, D.I. Soeteman, M.C. van der Veldt, M.J. Noom, W.B.F. Brouwer, J.J. van Busschbach & L. Hakkaart-van Roijen (2012). Framework for Modelling the Cost-effectiveness of Systemic Interventions Aimed to Reduce Youth Delinquency. The Journal of Mental Health Policy and Economics, 15, 187-196. doi: niet bekend
    • J.M. Tilford, N. Payakachat, E.M. Kovacs, J.M. Pyne, W.B.F. Brouwer, T.G. Nick, J. Bellando & K.A. Kuhlthau (2012). Preference-Based Health-Related Quality-of-Life Outcomes in Children with Autism Spectrum Disorders: A Comparison of Generic Instruments. Pharmacoeconomics (Print), 30 (8), 661-679. doi: http://dx.doi.org/10.2165/11597200[go to publisher's site]
    • D.R. Rappange & W.B.F. Brouwer (2012). The evaluation of lifestyle interventions in the Netherlands. Health Economics, Policy and Law, 7 (2), 243-261. doi: http://dx.doi.org/10.1017/S1744133112000023[go to publisher's site]
    • P. Makai, W.B.F. Brouwer, M.A. Koopmanschap & A.P. Nieboer (2012). Capabilities and quality of life in Dutch psycho-geriatric nursing homes: an exploratory study using a proxy version of the ICECAP-O. Quality of Life Research, 21, 801-812. doi: http://dx.doi.org/10.1007/s11136-011-9997-1
    • R.F. Pangalila, G.A.M. van den Bos, H.J. Stam, N.J.A. van Exel, W.B.F. Brouwer & M.E. Roebroeck (2012). Subjective caregiver burden of parents of adults with Duchenne. Disability & Rehabilitation, 34 (12), 988-996. doi: http://dx.doi.org/10.3109/09638288.2011.628738
    • H. Kraijo, W.B.F. Brouwer, R.N.H. De Leeuw, G. Schrijvers & N.J.A. van Exel (2012). Coping with caring: Profiles of caregiving by informal carers living with a loved one who has dementia. Dementia, 11 (1), 113-130. doi: http://dx.doi.org/10.1177/1471301211421261
    • A.E. Attema & W.B.F. Brouwer (2012). The way that you do it? An elaborate test of procedural invariance of TTO, using a choice-based design. The European Journal Of Health Economics, 13, 491-500. doi: http://dx.doi.org/10.1007/s10198-011-0318-y
    • L.M. Niëns, E. van de Poel, A. Cameron, M. Ewen, R. Laing & W.B.F. Brouwer (2012). Practical measurement of affordability: an application to medicines. Bulletin of the World Health Organization, 90, 219-227. doi: http://dx.doi.org/10.2471/BLT.10.084087
    • A.E. Attema & W.B.F. Brouwer (2012). A test of indepence of discounting from quality of life. Journal of Health Economics, 31, 22-34. doi: http://dx.doi.org/10.1016/j.jhealeco.2011.12.001
    • A.E. Attema & W.B.F. Brouwer (2012). Constantly Proving The Opposite? A test of CPTO using a broad time horizon and correcting for discounting. Quality of Life Research, 21 (1), 25-34. doi: http://dx.doi.org/10.1007/s11136-011-9917-4
    • H.M. Krol, W.B.F. Brouwer, J.L. Severens, J. Kaper & S.M.A.A. Evers (2012). Productivity cost calculations in health economic evaluations: Correcting for compensation mechanisms and multiplier effects. Social Science & Medicine, 75, 1981-1988. doi: http://dx.doi.org/10.1016/j.socscimed.2012.07.012
    • M.J. Poleij, W.B.F. Brouwer, N.J.A. van Exel & D. Tibboel (2012). Assessing health-related quality-of-life changes in informal caregivers: an evaluation in parents of children with major congenital anomalies. Quality of Life Research, 21 (5), 849-861. doi: 10.1007/s11136-011-9991-7
    • C.J. Tilling, H.M. Krol, A. Tsuchiya, J. Brazier, N.J.A. van Exel & W.B.F. Brouwer (2012). Does the EQ-5D Reflect Lost Earnings? Pharmacoeconomics (Print), 1 (30), 47-61. doi: http://dx.doi.org/10.2165/11539910-000000000-00000
    • P.H.M. van Baal, T.L. Feenstra, J.J. Polder, R.T. Hoogenveen & W.B.F. Brouwer (2011). Economic Evaluation and the postponement of health care costs. Health Economics, 20, 432-445. doi: http://dx.doi.org/10.1002/hec.1599
    • P.H.M. van Baal, A. Wong, L.C.J. Slobbe, J.J. Polder, W.B.F. Brouwer & G.A. de Wit (2011). Standardizing the Inclusion of Indirect Medical Costs in Economic Evaluations. Pharmacoeconomics (Print), 29 (3), 175-187. doi: http://dx.doi.org/10.2165/11586130-000000000-00000[go to publisher's site]
    • H.M. Krol, J. Papenburg, M.A. Koopmanschap & W.B.F. Brouwer (2011). Do Productivity Costs Matter? Pharmacoeconomics (Print), 7, 601-619.
    • J.F. O'Mahony, I.M.C.M. de Kok, J.M. van Rosmalen, J.D.F. Habbema, W.B.F. Brouwer & M. van Ballegooijen (2011). Practical implications of differential discounting in cost-effectiveness analyses with varying numbers of cohorts. Value in Health, 14 (4), 438-442. doi: http://dx.doi.org/10.1016/j.jval.2010.09.009
    • P.H.M. van Baal & W.B.F. Brouwer (2011). PAID 1.0 in Practice A Brief Clarification Regarding its Possibilities and Limitations. Pharmacoeconomics (Print), 29 (6), 545-547. doi: http://dx.doi.org/10.2165/11585600-000000000-00000
    • H. Kraijo, W.B.F. Brouwer, R. de Leeuw, G. Schrijvers & N.J.A. van Exel (2011). Coping with caring: Profiles of caregiving by informal carers living with a loved one who has dementia. Dementia, 11 (1), 113-130. doi: http://dx.doi.org/10.1177/1471301211421261
    • R.J. Hoefman, N.J.A. van Exel, M.M.E. Foets & W.B.F. Brouwer (2011). Sustained informal care: the feasibility, construct validity and test-retest reliability of the CarerQol-instrument to measure the impact of informal care in long-term care. Aging & Mental Health, 15 (8), 1-10. doi: http://dx.doi.org/10.1080/13607863.2011.575351
    • A. Bobinac, N.J.A. van Exel, F.F.H. Rutten & W.B.F. Brouwer (2011). Health Effects in Significant Others: Separating Family and Care-Giving Effects. Medical Decision Making, 4, 292-298. doi: http://dx.doi.org/10.1177/0272989X10374212
    • A. Bobinac, W.B.F. Brouwer & N.J.A. van Exel (2011). Discounting future health gains: an empirical enquiry into the influence of growing life expectancy. Health Economics, 20, 111-119. doi: http://dx.doi.org/10.1002/hec.1578
    • N. Payakachat, J.M. Tifford, W.B.F. Brouwer, N.J.A. van Exel & S.D. Grosse (2011). Measuring health and well-being effects in family caregivers of children with craniofacial malformations. Quality of Life Research, 20, 1487-1495. doi: http://dx.doi.org/10.1007/s11136-011-9870-2
    • R.J. Hoefman, N.J.A. van Exel, S. Looren-de Jong, W.K. Redekop & W.B.F. Brouwer (2011). A new test of the construct validity of the CarerQol instrument: measuring the impact of informal care giving. Quality of Life Research, 20, 875-887. doi: http://dx.doi.org/10.1007/s11136-010-9829-8
    • E.J. van de Wetering, N.J.A. van Exel & W.B.F. Brouwer (2010). Piecing the jigsaw puzzle of adolescent happiness. Journal of Economic Psychology, 31, 923-935. doi: http://dx.doi.org/10.1016/j.joep.2010.08.004
    • W.B.F. Brouwer & F.F.H. Rutten (2010). The efficiency frontier approach to economic evaluation: will it help German policy making? Health Economics, 19, 1128-1131. doi: http://dx.doi.org/10.1002/hec.1644
    • A. Bobinac, N.J.A. van Exel, F.F.H. Rutten & W.B.F. Brouwer (2010). Willingness to Pay for a Quality-Adjusted Life-Year: The Individual Perspective. Value in Health, 13 (8), 1049-1055. doi: http://dx.doi.org/10.1111/j.1524-4733.2010.00781.x
    • A.E. Attema & W.B.F. Brouwer (2010). The Value of Correcting Values: Influence and Importance of Correcting TTO Scores for Time Preference. Value in Health, 13 (8), 879-884. doi: http://dx.doi.org/10.1111/j.1524-4733.2010.00773.x
    • H. Al-Janabi, E. Frew, W.B.F. Brouwer, D.R. Rappange & N.J.A. van Exel (2010). The inclusion of positive aspects of caring in the Caregiver Strain Index: Tests of feasibility and validity. International Journal of Nursing Studies, 47, 984-993. doi: http://dx.doi.org/10.1016/j.ijnurstu.2009.12.015
    • L. Hakkaart-van Roijen, S.S. Tan, L.M.A. Goossens, S.J. Schawo, W.B.F. Brouwer, M.P.M.H. Rutten - van Molken & F.F.H. Rutten (2010). Doelmatigheid in praktijkrichtlijnen voor medicijnen: resultaten van een 'quick scan'. TSG, 4 (88), 175-181.
    • W.J. Meerding, G.J. Bonsel, W.B.F. Brouwer, M.C. Stuifbergen & M.L. Essink-Bot (2010). Social Time Preferences for Health and Money Elicited with a Choice Experiment. Value in Health, 13 (4), 368-374. doi: http://dx.doi.org/10.1111/j.1524-4733.2009.00681.x
    • D.R. Rappange, W.B.F. Brouwer, F.F.H. Rutten & P.H.M. van Baal (2010). Lifestyle intervention: from cost savings to value for money. Journal of Public Health, 32 (3), 440-447. doi: http://dx.doi.org/10.1093/pubmed/fdp079
    • A. Bobinac, N.J.A. van Exel, F.F.H. Rutten & W.B.F. Brouwer (2010). Caring for and caring about: Disentangling the caregiver effect and the family effect. Journal of Health Economics, 29, 549-556. doi: http://dx.doi.org/10.1016/j.jhealeco.2010.05.003
    • A.E. Attema & W.B.F. Brouwer (2010). On the (not so) constant proportional trade-off in TTO. Quality of Life Research, 19, 489-497. doi: http://dx.doi.org/10.1007/s11136-010-9605-9
    • C.A.M. de Meijer, W.B.F. Brouwer, M.A. Koopmanschap, B. van den Berg & N.J.A. van Exel (2010). The value of informal care-A further investigation of the feasibility of contingent valuation in informal caregivers. Health Economics, 19, 755-771. doi: http://dx.doi.org/10.1002/hec.1513
    • L.M. Niëns, A. Cameron, E. van de Poel, M. Ewen, W.B.F. Brouwer & R. Laing (2010). Quantifying the Impoverishing Effects of Purchasing Medicines: A Cross-Country Comparison of the Affordability of Medicines in the Developing World. PLoS Medicine (print), 7 (8), 1-8. doi: http://dx.doi.org/10.1371/journal.pmed.1000333
    • C.J. Tilling, H.M. Krol, A. Tsuchiya, J. Brazier & W.B.F. Brouwer (2010). In or Out? Income Losses in Health State Valuations: A Review. Value in Health, 13 (2), 298-305. doi: http://dx.doi.org/10.1111/j.1524-4733.2009.00614.x
    • A.E. Attema & W.B.F. Brouwer (2009). The correction of TTO-scores for utility curvature using a risk-free utility elicitation method. Journal of Health Economics, 28, 234-243. doi: http://dx.doi.org/10.1016/j.jhealeco.2008.10.004
    • W.B.F. Brouwer, S. Grootenboer & P. Sendi (2009). The Incorporation of Income and Leisure in Health State Valuations When the Measure Is Silent: An Empirical Inquiry into the Sound of Silence. Medical Decision Making, 29, 503-512. doi: http://dx.doi.org/10.1177/0272989X09336161
    • H.M. Krol, P. Sendi & W.B.F. Brouwer (2009). Breaking the Silence: Exploring the Potential Effects of Explicit Instructions on Incorporating Income and Leisure in TTO Exercices. Value in Health, 12 (1), 172-180. doi: http://dx.doi.org/10.1111/j.1524-4733.2008.00406.x
    • F.E. van Nooten, A.H.E. Koolman & W.B.F. Brouwer (2009). The influence of subjective life expectancy on health state valuations using a 10 year TTO. Health Economics, 18, 549-558. doi: http://dx.doi.org/10.1002/hec.1385
    • L.M. Niëns & W.B.F. Brouwer (2009). Better measures of affordability required. Lancet (UK), 373, 1081-1081. doi: http://dx.doi.org/10.1016/S0140-6736(09)60649-8
    • D.R. Rappange, W.B.F. Brouwer, R.T. Hoogenveen & P.H.M. van Baal (2009). Healthcare Costs and Obesity Prevention Drug Costs and Other Sector-Specific Consequences. Pharmacoeconomics (Print), 27 (12), 1031-1044. doi: http://dx.doi.org/10.2165/11319900-000000000-00000
    • D.R. Rappange, W.B.F. Brouwer & N.J.A. van Exel (2009). Back to the Consideration of Future Consequences Scale: Time to Reconsider? The Journal of Social Psychology, 149 (5), 562-584. doi: http://dx.doi.org/10.1080/00224540903232324
    • J. Holland, N.J.A. van Exel, F.T. Schut & W.B.F. Brouwer (2009). Some pain, no gain: experiences with the no-claim rebate in the Dutch health care system. Health Economics, Policy and Law, 4, 405-424. doi: http://dx.doi.org/10.1017/S1744133109004861
    • D.R. Rappange, P.H.M. van Baal, N.J.A. van Exel, T.L. Feenstra, F.F.H. Rutten & W.B.F. Brouwer (2009). I costi sanitari indiretti (non correlati) durante gli anni di vita guadagnati: : Devono essere inclusi nelle valutazioni economiche degli interventi sanitari? Pharmacoeconomics Italian Research Articles, 11 (1), 55-70.
    • A.C.G. van Hooren, W.B.F. Brouwer, R. de Bree, O.S. Hoekstra, C.R. Leemans & C.A. de Uyl-de Groot (2009). The cost-effectiveness of FDG-PET in selecting patients with suspicion of recurrent laryngeal carcinoma after radiotherapy for direct laryngoscopy. European Archives of Oto-Rhino-Laryngology, 266 (9), 1441-1448.
    • M.J. Poleij, E.A. Stolk & W.B.F. Brouwer (2009). The use and impact of HTA in decision making in the Netherlands. Euro Observer, 11 (1), 7-8.
    • N.J.A. van Exel, M. de Ruiter & W.B.F. Brouwer (2008). When time is not on your side. Patient experiences with waiting for home care and admission to a nursing or residential home. Patient 2008, 1 (1), 55-71.
    • W.B.F. Brouwer, A.J. Culyer, N.J.A. van Exel & F.F.H. Rutten (2008). Welfarism vs. extra-welfarism. Journal of Health Economics, 27, 325-338. doi: http://dx.doi.org/10.1016/j.jhealeco.2007.07.003
    • N.J.A. van Exel, G. de Graaf & W.B.F. Brouwer (2008). Give me a break! Informal caregiver attitudes towards respite care. Health Policy, 88, 73-87. doi: http://dx.doi.org/10.1016/j.healthpol.2008.03.001
    • D.R. Rappange, P.H.M. van Baal, F.F.H. Rutten, N.J.A. van Exel, T.L. Feenstra & W.B.F. Brouwer (2008). Unrelated medical costs in life-years gained should they be included in economic evaluations of healthcare interventions? Pharmacoeconomics (Print), 26 (10), 815-860. doi: http://dx.doi.org/10.2165/00019053-200826100-00003
    • M.J. Poleij, W.B.F. Brouwer, J.J.V. van Busschbach, F.W.J. Hazebroek, D. Tibboel, F.F.H. Rutten & J.C. Molenaar (2008). Cost-effectiveness of neonatal surgery: first greeted with scepticism, now increasingly accepted. Pediatric Surgery International, 24 (2), 119-127. doi: http://dx.doi.org/10.1007/s00383-007-2045-0
    • A.E. Attema & W.B.F. Brouwer (2008). Can we fix it? Yes we can! But what? A new test of procedural invariance in TTO-measurement. Health Economics, 17, 877-885. doi: http://dx.doi.org/10.1002/hec.1315
    • M.A. Koopmanschap, N.J.A. van Exel, B. van den Berg & W.B.F. Brouwer (2008). An overview of methods and applications to value informal care in economic evaluations of healthcare. Pharmacoeconomics (Print), 26 (4), 269-280. doi: http://dx.doi.org/10.2165/00019053-200826040-00001
    • W.B.F. Brouwer, N.J.A. van Exel, R. Baker & C. Donaldson (2008). The New Myth The Social Value of QUALY. Pharmacoeconomics (Print), 26 (1), 1-4.
    • T.L. Feenstra, P.H.M. van Baal, A. Gandjour & W.B.F. Brouwer (2008). Future medical costs in economic evaluations. A comment on Lee. Journal of Health Economics, 27 (6), 1645-1649. doi: http://dx.doi.org/10.1016/j.jhealeco.2008.07.007
    • N.J.A. van Exel, A. Bobinac, M.A. Koopmanschap & W.B.F. Brouwer (2008). The invisible hands made visible: Recognizing the value of informal care in health care decision making. Expert review of pharmacoeconomics & outcomes research, 8 (6), 557-561. doi: http://dx.doi.org/10.1586/14737167.8.6.557
    • W.B.F. Brouwer (2008). Perspective, costs, outcomes and discouting in economic evaluations. European Journal of Hospital Pharmacy Practice, 14 (3), 20-22.
    • P.H.M. van Baal, J.J. Polder, G.A. de Wit, R.T. Hoogeveen, T.L. Feenstra, H.C. Boshuizen, P. Engelfriet & W.B.F. Brouwer (2008). Lifetime medical costs of obesity: pevention no cure for increasing health expenditure. PLoS Medicine (print), 5 (2), 242-249. doi: http://dx.doi.org/10.1371/journal.pmed.0050029
    • B. van den Berg, M.J. Al, N.J.A. van Exel, M.A. Koopmanschap & W.B.F. Brouwer (2008). Economic valuation of informal care: conjoint analysis applied in a heterogeneous population of informal caregivers. Value in Health, 11 (7), 1041-1050. doi: http://dx.doi.org/10.1111/j.1524-4733.2008.00357.x
    • N.J.A. van Exel, A. Bobinac, M.A. Koopmanschap & W.B.F. Brouwer (2007). Providing informal care: a burden and a blessing. Health and Ageing, 16, 10-13.
    • P. Sendi, W.B.F. Brouwer, H. Bucher, R. Weber & M. Battegay (2007). When time is more than money; The allocation of time between work and leisure in HIV-infected patients. Social Science & Medicine, 64, 2355-2361. doi: http://dx.doi.org/10.1016/j.socscimed.2007.02.032
    • W.B.F. Brouwer, N.J.A. van Exel, P.H.M. van Baal & J. Polder (2007). Economics and public health: Engaged to be happily married! European Journal of Public Health, 17 (2), 122-123. doi: http://dx.doi.org/10.1093/eurpub/ckl074
    • N.J.A. van Exel, G. de Graaf & W.B.F. Brouwer (2007). Care for a break? An investigation of informal caregivers' attitudes toward respite care using Q-methodology. Health Policy, 83, 332-342. doi: http://dx.doi.org/10.1016/j.healthpol.2007.02.002
    • H. Gravelle, W.B.F. Brouwer, L.W. Niessen, M. Postma & F.F.H. Rutten (2007). Discouting in economic evaluations: stepping forward towards optima decision rules. Health Economics, 16, 307-317. doi: http://dx.doi.org/10.1002/hec.1168
    • P.H.M. van Baal, W.B.F. Brouwer, R.T. Hoogeveen & T.L. Feenstra (2007). Increasing tobacco taxes: A cheap tool to increase public health. Health Policy, 82, 142-152. doi: http://dx.doi.org/10.1016/j.healthpol.2006.09.004
    • P.H.M. van Baal, T.L. Feenstra, R.T. Hoogenveen, G.A. de Wit & W.B.F. Brouwer (2007). Unrealated medical care in life years gained and the cost utility of primary prevention: in search of a 'perfect' cost-utility ratio. Health Economics, 16, 421-433. doi: http://dx.doi.org/10.1002/hec.1181
    • W.B.F. Brouwer, N.J.A. van Exel, R.M.P.M. Baltussen & F.F.H. Rutten (2006). A Dollar is a Dollar Is a Dollar - or Is It? Value in Health, 9 (5), 341-347. doi: http://dx.doi.org/10.1111/j.1524-4733.2006.00123.x
    • N.J.A. van Exel, M. Moree, M.A. Koopmanschap, T. Scheuder Goedheijt & W.B.F. Brouwer (2006). Respite care- An explorative study of demand and use in Dutch informal caregivers. Health Policy, 78, 194-198. doi: http://dx.doi.org/10.1016/j.healthpol.2005.11.002
    • W.B.F. Brouwer, N.J.A. van Exel, B. van Gorp & W.K. Redekop (2006). The CarerQol instrument: A new instrument to measure care-related quality of life of informal caregivers for use in economic evaluations. Quality of Life Research, 15, 1005-1021. doi: http://dx.doi.org/10.1007/s11136-005-5994-6
    • W.B.F. Brouwer (2006). Too Important to Ignore. Pharmacoeconomics (Print), 24, 39-41.
    • H.M. Krol, W.B.F. Brouwer & P. Sendi (2006). Productivity Costs in Health -State Valuations. Pharmacoeconomics (Print), 24, 401-414.
    • N.J.A. van Exel, W.B.F. Brouwer, B. van den Berg & M.A. Koopmanschap (2006). With a little help from an anchor; Discussion and evidence of anchoring effects in contigent valuation. Journal of Socio-economics, 35, 836-853.
    • B. van den Berg, W.B.F. Brouwer, N.J.A. van Exel, M.A. Koopmanschap, G. van den Bos & F.F.H. Rutten (2006). Economic valuation of informal care: Lessons from the application of the oppurtunity costs and proxy good methods. Social Science & Medicine, 62, 835-845. doi: http://dx.doi.org/10.1016/j.socscimed.2005.06.046
    • P. Sendi & W.B.F. Brouwer (2005). Is silence golden? A test of the incorporation of the effects of ill-health on income and leisure in health state valuations. Health Economics, 14 (6), 643-647. doi: http://dx.doi.org/10.1002/hec.971
    • M.A. Koopmanschap, W.B.F. Brouwer, L. van Roijen & N.J.A. van Exel (2005). Influence of waiting time on cost-effectiveness. Social Science & Medicine, 60 (11), 2501-2504. doi: http://dx.doi.org/10.1016/j.socscimed.2004.11.022
    • W.B.F. Brouwer & M.A. Koopmanschap (2005). The friction-cost method - Replacement for nothing and leisure for free? Pharmacoeconomics (Print), 23 (2), 105-111. doi: http://dx.doi.org/10.2165/00019053-200523020-00002
    • N.J.A. van Exel, M.A. Koopmanschap, B. van der Berg, W.B.F. Brouwer & G. van den Bos (2005). Burden of informal caregiving for stroke patients - Identification of caregivers at risk of adverse health effects. Cerebrovascular Diseases, 19 (1), 11-17. doi: http://dx.doi.org/10.1159/000081906
    • M.A. Koopmanschap, A. Burdorf, K. Jacob, W.J. Meerding, W.B.F. Brouwer & J.L. Severens (2005). Productivity and health in economic evaluation; setting the research agenda. Pharmacogenetics, 23, 47-54.
    • F.F.H. Rutten, W.B.F. Brouwer & L.W. Niessen (2005). Practice guidelines based on clinical and economic evidence: indispensable tools in future market-oriented health care. European Journal of Health Economics (HEPAC), 6, 91-93. doi: http://dx.doi.org/10.1007/s10198-005-0278-1
    • P. de Wolf, W.B.F. Brouwer & F.F.H. Rutten (2005). Regulating the Dutch pharmaceutical market: improving efficiency or controlling costs? International Journal of Health Planning and Management, 20 (4), 351-374. doi: http://dx.doi.org/10.1002/hpm.819
    • K. Lee, W.B.F. Brouwer, S. Lee & H. Koo (2005). Introducing economic evaluation as a policy tool in Korea: Will decision makers get quality information? A critical review of published Korean economic evaluations. Pharmacoeconomics (Print), 23 (7), 709-721. doi: http://dx.doi.org/10.2165/00019053-200523070-00005
    • S. Polinder, W.J. Meerding, N.J.A. van Exel & W.B.F. Brouwer (2005). Societal discounting of health effects in cost-effectiveness analyses: the influence of life expectancy. Pharmacoeconomics (Print), 23, 791-802.
    • R. Klok, W.B.F. Brouwer, L. Annemans, J.M. Bos & M.J. Postma (2005). Towards a healthier discount procedure. Expert review of pharmacoeconomics & outcomes research, 5, 59-63. doi: http://dx.doi.org/10.1586/14737167.5.1.59
    • L.M. Lamers, W.J. Meerding, J.L. Severens & W.B.F. Brouwer (2005). The relationship between productivity and health-related quality of life: An empirical exploration in persons with low back pain. Quality of Life Research, 14 (3), 805-813. doi: http://dx.doi.org/10.1007/s11136-004-0800-4
    • W.B.F. Brouwer, W.J. Meerding, L.M. Lamers & J.L. Severens (2005). The relationship between productivity and health-related QOL: an exploration. Pharmacoeconomics (Print), 23 (3), 209-218. doi: http://dx.doi.org/10.2165/00019053-200523030-00002
    • W.B.F. Brouwer, N.J.A. van Exel, B. van der Berg, G. van den Bos & M.A. Koopmanschap (2005). Process utility from providing informal care: the benefit of caring. Health Policy, 74 (1), 85-99. doi: http://dx.doi.org/10.1016/j.healthpol.2004.12.008
    • W.B.F. Brouwer, L.W. Niessen, M.J. Postma & F.F.H. Rutten (2005). Need for differential discounting of costs and health effects in cost effectiveness analyses. British Medical Journal, 331 (7514), 446-448.
    • W.B.F. Brouwer & N.J.A. van Exel (2005). Expectations regarding length and health related quality of life: Some empirical findings. Social Science & Medicine, 61 (5), 1083-1094. doi: http://dx.doi.org/10.1016/j.socscimed.2005.01.008
    • W.B.F. Brouwer, N.J.A. van Exel & E.A. Stolk (2005). Acceptability of less than perfect health states. Social Science & Medicine, 60, 237-246. doi: http://dx.doi.org/10.1016/j.socscimed.2004.04.032
    • N.J.A. van Exel, B. van den Berg, M.A. Koopmanschap & W.B.F. Brouwer (2004). Mantelzorg: een goed om te waarderen. Nederlands Tijdschrift voor Geneeskunde, 82, 236-242.
    • N.J.A. van Exel, W.J.M. Scholte op Reimer, W.B.F. Brouwer, B. van den Berg, M.A. Koopmanschap & G. van den Bos (2004). Instruments for assessing the burden of informal caregiving for stroke patients in clinical practice: a comparison of CSI, CRA, SCQ and self-rated burden. Clinical Rehabilitation, 18, 203-214. doi: http://dx.doi.org/10.1191/0269215504cr723oa
    • W.B.F. Brouwer & F.F.H. Rutten (2004). Modernisering GVS:een contradictio in terminis? Nederlands Tijdschrift voor Geneeskunde, 82, 463-466.
    • P. Sendi & W.B.F. Brouwer (2004). Leisure time in economic evaluation: theoretical and practical considerations. Expert review of pharmacoeconomics & outcomes research, 4, 1-3. doi: http://dx.doi.org/10.1586/14737167.4.1.1
    • M.J. Al & W.B.F. Brouwer (2004). Decision makers views on health care objectives and budget constraints; results from a pilot. Health Policy, 70, 33-48. doi: http://dx.doi.org/10.1016/j.healthpol.2004.01.009
    • W.B.F. Brouwer & N.J.A. van Exel (2004). Discounting in decision making: the consistency argument revisited empirically. Health Policy, 67, 187-194. doi: http://dx.doi.org/10.1016/S0168-8510(03)00115-5
    • W.B.F. Brouwer, N.J.A. van Exel, B. van den Berg & H.J. Dinant (2004). Burden of caregiving: evidence of objective burden, subjective burden, and quality of life impacts on informal caregivers of patients with rheumatoid arthritis. Arthritis & Rheumatism, 51, 570-577.
    • M.A. Koopmanschap, N.J.A. van Exel, G. van den Bos, B. van den Berg & W.B.F. Brouwer (2004). The desire for support and respite care:preferences of Dutch informal caregivers. Health Policy, 68, 309-320. doi: http://dx.doi.org/10.1016/j.healthpol.2003.10.002
    • F.E. van Nooten & W.B.F. Brouwer (2004). The influence of subjective expectations about length and quality of life on time trade-off answers. Health Economics, 13, 819-823. doi: http://dx.doi.org/10.1002/hec.873
    • E.A. Stolk, G. van Donselaar, W.B.F. Brouwer & J.J. van Busschbach (2004). Reconciliation of economic concerns and health policy;illustration of an equity adjustment procedure using proportional shortfall. Pharmacoeconomics (Print), 22, 1097-1107. doi: http://dx.doi.org/10.2165/00019053-200422170-00001
    • B. van den Berg, W.B.F. Brouwer & M.A. Koopmanschap (2004). Economic valuation of informal care. European Journal of Health Economics (HEPAC), 5, 36-45.
    • N.J.A. van Exel & W.B.F. Brouwer (2004). What really matters: an inquiry into the relative importance of dimensions of informal caregiver burden. Clinical Rehabilitation, 18, 683-693. doi: http://dx.doi.org/10.1191/0269215504cr743oa
    • F. Paolucci & W.B.F. Brouwer (2003). Introduzione ad alcuni aspetti di economia sanitaria. Quadernie Associazione Culturale Pediatri, 10, 25-27.
    • W.B.F. Brouwer, N.J.A. van Exel, B. Hermans & A.P. Stoop (2003). Should I stay or should I go? Waiting lists and cross-border care in the Netherlands. Health Policy, 63, 289-298. doi: http://dx.doi.org/10.1016/S0168-8510(02)00120-3
    • W.B.F. Brouwer & F.F.H. Rutten (2003). The missing link: on the line between C and E. Health Economics, 12, 629-636. doi: http://dx.doi.org/10.1002/hec.764
    • M.J. Poleij, E.A. Stolk, W.B.F. Brouwer & J.J. van Busschbach (2002). Ziektelast als uitwerking van het criterium 'noodzakelijkheid' bij het maken van keuzen in de zorg. Nederlands Tijdschrift voor Geneeskunde, 146 (48), 2312-2315.
    • E.A. Stolk, W.B.F. Brouwer & J.J. van Busschbach (2002). Rationalising rationing: economic and other considerations in the debate about funding of Viagra. Health Policy, 59, 53-63. doi: http://dx.doi.org/10.1016/S0168-8510(01)00162-2
    • W.B.F. Brouwer, N.J.A. van Exel, M.A. Koopmanschap & F.F.H. Rutten (2002). Productivity losses before and after absence: as important as common? Health Policy, 61, 173-187.
    • F.F.H. Rutten & W.B.F. Brouwer (2002). Meer zorg bij beperkt budget; een pleidooi voor een betere inzet van het doelmatigheidscriterium. Nederlands Tijdschrift voor Geneeskunde, 146 (47), 2254-2258.
    • G.T. Koopmans & W.B.F. Brouwer (2001). Comparing patients with depressive complaints and patients with chronic medical conditions on their functioning and medical consumption. Journal of Mental Health Policy and Economics, 4, 91-100.
    • W.B.F. Brouwer & F.F.H. Rutten (2001). Health economics: a bridge over troubled water. European Journal of Public Health, 11, 234-236. doi: http://dx.doi.org/10.1093/eurpub/11.2.234
    • F.F.H. Rutten, H. Bleichrodt, W.B.F. Brouwer, M.A. Koopmanschap & F.T. Schut (2001). Book review Handbook of health economics. Journal of Health Economics, 20, 855-879.
    • E.K.A. van Doorslaer & W.B.F. Brouwer (2000). Editorial: Waiting lists in the Netherlands: workers first? Journal of Health Services Research & Policy, 5 (3), 129-130.
    • W.B.F. Brouwer & M.A. Koopmanschap (2000). On the economic foundations of CEA. Ladies and gentlemen, take your positions! Journal of Health Economics, 19, 439-459.
    • W.B.F. Brouwer, B.A. van Hout & F.F.H. Rutten (2000). A fair approach to discounting future effects: taking a societal perspective. Journal of Health Services Research & Policy, 5 (2), 114-118.
    • W.B.F. Brouwer & M.A. Koopmanschap (2000). On the economic foundations of CEA. Ladies and gentlemen, take your positions! Journal of Health Economics, 19, 439-459.
    • W.B.F. Brouwer, B.A. van Hout & F.F.H. Rutten (2000). A fair approach to discounting future effects: taking a societal perspective. Journal of Health Services Research & Policy, 5 (2), 114-114.
    • W.B.F. Brouwer & F.T. Schut (1999). Priority care for employees: a blessing in disguise? Health Economics, 65-73.
    • W.B.F. Brouwer, N.J.A. van Exel, M.A. Koopmanschap & F.F.H. Rutten (1999). The valuation of informal care in economic appraisal. International Journal of Technology Assessment in Health Care, 15 (1), 147-160.
    • W.B.F. Brouwer & H.E.G.M. Hermans (1999). Private clinics for employees as a Dutch solution for waiting lists: economic and legal arguments. Health Policy, 1-17. doi: http://dx.doi.org/10.1016/S0168-8510(99)00005-6
    • W.B.F. Brouwer, M.A. Koopmanschap & F.F.H. Rutten (1999). Productivity losses without absence. Health Policy, 13-27.
    • W.B.F. Brouwer (1999). Market Limitations in the health care sector. Journal of Health Services Research & Policy, 4 (3), 185-186.
    • W.B.F. Brouwer, M.A. Koopmanschap & F.F.H. Rutten (1998). Patient and informal caregiver time in cost- effectiveness analysis. International Journal of Technology Assessment in Health Care, 14 (3), 505-513.
    • W.B.F. Brouwer & F.F.H. Rutten (1998). Wachtlijsten en bedrijvenpoli's. Tijdschrift voor Bedrijfs- en Verzekeringsgeneeskunde, 6 (2), 51-54.
    • H.E.G.M. Hermans & W.B.F. Brouwer (1998). Bedrijvenpoli's leiden tot tweedeling in de zorg: mythe of realiteit? Nederlands Juristenblad (NJB), 25, 1095-1101.
    • W.B.F. Brouwer & B.A. van Hout (1998). How should different life expectancies be valued? British Medical Journal, 317, 317-317.
    • J.J. van Busschbach, W.B.F. Brouwer, A. van der Donk & J. Passchier (1998). An Outline for a Cost-Effectiveness Analysis of a Drug for Patients with Alzheimer's Disease. Pharmacoeconomics (Print), 13, 21-34.
    • J.J. van Busschbach, W.B.F. Brouwer, A. van der Donk & J. Passchier (1998). An outline for a cost-effectiviness analysis of a drug for patients with Alzheimer's disease. Pharmacoeconomics (Print), 13 (1 Pt 1), 21-34.
    • M.A. Koopmanschap & W.B.F. Brouwer (1998). Indirect Costs and Costing Informal Care. Health Economics Approaches to Dementia, 245-256.
    • W.B.F. Brouwer, F.T. Schut & F.F.H. Rutten (1997). De opvattingen van Rawls. Economisch-Statistische Berichten, 82 (4094), 153-154.
    • W.B.F. Brouwer, M.A. Koopmanschap & F.F.H. Rutten (1997). Productivity costs in cost-effectiveness analysis numerator or denominator: a further discussion. Health Economics, 511-514.
    • W.B.F. Brouwer, M.A. Koopmanschap & F.F.H. Rutten (1997). Productivity costs measurement through quality of life? A response to the recommendation of the Washington Panel. Health Economics, 253-259.
    • J.J. van Dijk & W.B.F. Brouwer (1996). Salomo en de speltheorie. Economisch-Statistische Berichten, oktober, 2-2.
    • W.B.F. Brouwer & J.J. van Dijk (1996). Salomo en de speltheorie. Economisch-Statistische Berichten, 836-837.
    • W.B.F. Brouwer, F.T. Schut & F.F.H. Rutten (1996). Bedrijvenpoli in het licht van Rawls en Pareto. Economisch-Statistische Berichten, 973-975.

  • Professional Publication (66)

    • W.B.F. Brouwer, N.J.A. van Exel & R.J. Hoefman (2014). Zorgen voor geluk. M en O, 124-132.
    • T.A. Westra, M. Parouty, W.B.F. Brouwer, P. Beutels, R.M. Rogoza, M.H. Rozenbaum, T. Daemen, J.C. Wilschut, C. Boersma & M.J. Postma (2012). Discounting of Health Gains from Human Papillomavirus Vaccination: Effects of Different Approaches. Value in Health, 15 (3), 562-567. doi: 10.1016
    • W.B.F. Brouwer & N.J.A. van Exel (2012). Een gepaste waarde van gezondheid. Economisch-Statistische Berichten, 97 (4644S), 50-58. doi: niet bekend
    • W.B.F. Brouwer (2012). Het complexe dossier gepaste zorg. Economisch-Statistische Berichten, 97 (4644s), 6-14. doi: niet bekend
    • E.J. van de Wetering, N.J.A. van Exel & W.B.F. Brouwer (2011). De puzzel van geluk en gezondheid van pubers. VGE Bulletin, 2, 3-6.
    • R.J. Hoefman, N.J.A. van Exel & W.B.F. Brouwer (2010). Laat zorgverlener bij ouderenzorg samenwerken met vrienden en familie. VGE Bulletin, 10, 16-18.
    • F.F.H. Rutten & W.B.F. Brouwer (2010). Behoedzaam bezuinigen in de zorg. Economisch-Statistische Berichten, 95 (4586), 343-344.
    • R.J. Hoefman, N.J.A. van Exel & W.B.F. Brouwer (2010). Het meten en waarderen van mantelzorg met CarerQol. TSG, 88 (4), 172-176.
    • J. Polder & W.B.F. Brouwer (2008). Tien woorden gezondheidseconomie. 4. Rechtvaardige verdeling: het verhaal van Bart, Werner, Johan en Kees. TSG, 63-68.
    • P.H.M. van Baal, W.B.F. Brouwer, G.A. de Wit, R.T. Hoogeveen & J.J. Polder (2008). De invloed van roken en overgewicht op zorguitgaven. TSG, 86 (3), 150-155.
    • W.B.F. Brouwer, N.J.A. van Exel & P.H.M. van Baal (2008). Kosten in de gewonnen levensjaren niet langer negeren! TSG, 86 (1), 1-1.
    • W.B.F. Brouwer & J. Polder (2007). Nuttige verzekering: Het verhaal van Kees, Truus, Bert & Bertine en Al. TSG, 85 (6), 303-305.
    • W.B.F. Brouwer & E.A. Stolk (2007). De grenzen van het pakket. IKR-bulletin (Rotterdam), 31, 22-23.
    • F.F.H. Rutten & W.B.F. Brouwer (2007). "Value for money" in de zorg; geen woorden maar daden. M en O, 61, 171-179.
    • J. Polder & W.B.F. Brouwer (2007). Een mistroostige wetenschap? TSG, 85 (4), 202-204.
    • W.B.F. Brouwer, N.J.A. van Exel & P.H.M. van Baal (2007). De kosten in gewonnen levensjaren - tijd voor een nieuwe richtlijn! VGE Bulletin, 24 (1), 11-14.
    • W.B.F. Brouwer (2007). De markt is geen zorg! TSG, 4 (84), 193-194.
    • W.B.F. Brouwer & J.J. Polder (2007). Gereguleerde concurrentie: broodnodig. Tien woorden gezondheidseconomie. TSG, 85 (8), 417-422.
    • W.B.F. Brouwer, N.J.A. van Exel, J. Polder & P.H.M. van Baal (2006). Gezond leven niet per se goedkoper. Medisch Contact, 61 (21), 878-881.
    • W.B.F. Brouwer, P.H.M. van Baal & N.J.A. van Exel (2006). De dubbele prijs van succes: The pain is in the gain. TSG, 84, 7-10.
    • G. de Graaf, W.B.F. Brouwer & N.J.A. van Exel (2006). Gezondheidshoudingen van jongeren in klas 1 en 2 van het voortgezet onderwijs. TSG, 4, 215-222.
    • W.B.F. Brouwer (2006). Economie is goed voor volksgezondheid en zorg! TSG, 84 (5), 3-3.
    • N.J.A. van Exel, M. Moree, M.A. Koopmanschap, T. Schreuder Goedheijt & W.B.F. Brouwer (2006). Respijtzorg: Een verkenning van behoefte en gebruik onder 273 mantelzorgers. TSG, 84 (2), 90-99.
    • Y.W. van Kemenade & W.B.F. Brouwer (2006). Lang verwacht en toch gekomen: de stelselherziening. ZM Magazine, 2, 6-9.
    • I.C.S. Maas, W.B.F. Brouwer & N.J.A. van Exel (2006). Zorg in eigen regie, of liever niet? Houdingen onder mensen van 55 jaar enouden ten aanzien van het PGB als alternatief voor zorg in natura. TSG, 84 (7), 394-402.
    • W.B.F. Brouwer, N.J.A. van Exel & F.T. Schut (2006). De markt is geen zorg! TSG, 84 (4), 193-194.
    • W.B.F. Brouwer & F. Calkoen (2006). Keuzen in de Zorg Moeilijk maar noodzakelijk. Nederlands Tijdschrift voor Mondhygiene, 18-21.
    • W.B.F. Brouwer (2005). Ongelijkheid om positief te prikkelen: nuttig en rechtvaardig. TSG, 83, 181-182.
    • W.B.F. Brouwer & F.F.H. Rutten (2005). Optimale zorg dient onafhankelijk te worden vastgesteld, juist nu! TSG, 83 (5), 326-329.
    • F.T. Schut & W.B.F. Brouwer (2004). De preferente apotheker? Jazeker! Economisch-Statistische Berichten, 269.
    • W.B.F. Brouwer & F.F.H. Rutten (2004). Met het oog op gepaste zorg. RVZ, 7, 53-53.
    • W.B.F. Brouwer & F.F.H. Rutten (2004). Bittere pillen. Medisch Contact, 59, 1114-1116.
    • W.B.F. Brouwer, F.E. van Nooten & F.F.H. Rutten (2004). Nog veel te winnen met betere richtlijnen. TSG, 8, 523-526.
    • M.J. Al & W.B.F. Brouwer (2004). Stimuleren doelmatig gebruik van zuurpompremmers in de onderhoudsbehandeling. TSG, 82, 191-195.
    • G.A. de Wit & W.B.F. Brouwer (2004). Economische evaluaties van gvo-programma's. Forum, 120-123.
    • N.J.A. van Exel & W.B.F. Brouwer (2003). Jeugdroken: rol voor overheid en ouders. TSG, 81, 24-26.
    • N.J.A. van Exel, M.A. Koopmanschap & W.B.F. Brouwer (2003). Kostbaar ontslag, korte verpleegduur brengt mantelzorgers in de problemen. Medisch Contact, 58, 1272-1274.
    • W.B.F. Brouwer, M.A.J.M. Buijsen & F.F.H. Rutten (2003). Op naar een nationaal instituut voor effectiviteit en doelmatigheid in de zorg. TSG, 81, 293-296.
    • W.B.F. Brouwer, E.H. Hulst, F.E. van Nooten & F.F.H. Rutten (2003). Generieke substitutie. TSG, 81, 162-165.
    • W.B.F. Brouwer (2003). Regeren is vooruitzien, niet achterom kijken. TSG, 81, 307-308.
    • W.B.F. Brouwer & F.F.H. Rutten (2003). Besparen in de praktijk. Medisch Contact, 58, 1406-1408.
    • I.M. van Exel, N.J.A. van Exel & W.B.F. Brouwer (2002). Het notariaat aan banden. Economisch-Statistische Berichten, 87, 151-153.
    • M.J. Poleij, E.A. Stolk, W.B.F. Brouwer & J.J. van Busschbach (2002). Ziektelast als criterium: Overheid wil geneesmiddelen beperken. Medisch Contact, 57 (46), 1697-1700.
    • W.B.F. Brouwer, A.H.E. Koolman & M.A.J.M. Buijsen (2002). Grenzeloos informeren. Medisch Contact, 57 (39), 737-740.
    • W.B.F. Brouwer & F.F.H. Rutten (2002). Een gouden pil voor apothekers. Generiek voorschrijven is nauwelijks kostenbesparend. Medisch Contact, 57 (19), 737-740.
    • W.B.F. Brouwer, N.J.A. van Exel & A.P. Stoop (2002). Grensoverschrijdende zorg niet in trek. Economisch-Statistische Berichten, 87, 30-31.
    • W.B.F. Brouwer & F.F.H. Rutten (2002). Geef de dokter maar de schuld. Medisch Contact, 57 (14), 540-541.
    • W.B.F. Brouwer, H.E.G.M. Hermans & E.K.A. van Doorslaer (2001). Zorg in en om Europa. ZorgVisie (Maarssen), 3, 24-29.
    • W.B.F. Brouwer & F.T. Schut (2001). Ethische dilemma,s in het nieuwe zorgstelsel. Economisch-Statistische Berichten, 7, 1-1.
    • W.B.F. Brouwer & F.F.H. Rutten (2001). GVS geeft verkeerde signalen. Economisch-Statistische Berichten, 86, 884-888.
    • N.J.A. van Exel & W.B.F. Brouwer (2001). Lekker belangrijk. Economisch-Statistische Berichten, 16 (2-01), 155-157.
    • W.B.F. Brouwer & N.J.A. van Exel (2001). Zorgelijk vervoersbeleid. Economisch-Statistische Berichten, 86, 328-329.
    • W.B.F. Brouwer & H.E.G.M. Hermans (2001). Europese regelgeving grijpt in op nationaal zorgstelsel. TSG, 79 (3), 176-179.
    • A.P. Stoop & W.B.F. Brouwer (2001). De patiënt achter de cijfers. Medisch Contact, 56 (44), 1610-1612.
    • B. van den Berg, W.B.F. Brouwer & M.A. Koopmanschap (2000). Recht op thuiszorg; hoe zijn de wachttijden op korte termijn te reduceren? Medisch Contact, 55 (3), 93-96.
    • E.A. Stolk, W.B.F. Brouwer & J.J. van Busschbach (2000). Vergoeding van viagra stuit op waarden en normen. Medisch Contact, 55 (17), 626-629.
    • W.B.F. Brouwer (2000). Het verdelen van de schaarste; over het nut van gezondheidseconomisch onderzoek. Medisch Contact, 55 (25), 939-942.
    • E.A. Stolk, W.B.F. Brouwer & J.J. van Busschbach (2000). Vergoeding van viagra stuit op waarden en normen. Medisch Contact, 55 (17), 626-629.
    • W.B.F. Brouwer (2000). Het verdelen van de schaarste; over het nut van gezondheidseconomisch onderzoek. Medisch Contact, 55 (25), 939-942.
    • F.T. Schut & W.B.F. Brouwer (2000). Arbeidsdeling. Economisch-Statistische Berichten, 85, 10-13.
    • N.J.A. van Exel, W.B.F. Brouwer & J.J. van Dijk (1999). Speltheorie: Voetbal, vechten en vliegen. Factor D, 10-14.
    • W.B.F. Brouwer, J.J. Dijk van & N.J.A. van Exel (1998). Een economische vakantie. Tijdschrift voor Vervoerswetenschap, 3, 317-323.
    • W.B.F. Brouwer, J.J. van Dijk & N.J.A. van Exel (1998). De markt voor gebruikte auto's: reputatie- effecten. Tijdschrift voor Vervoerswetenschap, 2, 137-144.
    • W.B.F. Brouwer, J. Dijk van & N.J.A. van Exel (1998). Speltheorie: een inleiding. Tijdschrift voor het Economisch Onderwijs, 195-198.
    • H.E.G.M. Hermans & W.B.F. Brouwer (1998). Naschrift. Nederlands Juristenblad (NJB), 40, 1823-1824.
    • W.B.F. Brouwer, F.T. Schut & F.F.H. Rutten (1997). Naschrift. Economisch-Statistische Berichten, 153-154.

• Book / Monograph / Book editorial (3)

  • Scholarly Publication (2)

    • R.E. Leu, F.F.H. Rutten, W.B.F. Brouwer, C. Rutschi & P. Matter (2008). The Swiss and the Dutch health care systems compared. Baden Baden: Nomos
    • W.B.F. Brouwer (1999). Time and time costs in economic evaluation: taking a societal perspective. Ridderkerk: Ridderprint

  • Professional Publication (1)

    • W.B.F. Brouwer, F.F.H. Rutten, J.L. Severens, P.H.M. van Baal, T.E.D. van der Grinten, A.H.E. Koolman & N.J.A. van Exel (2011). Economie van de volksgezondheid. Assen: Koninklijke van Gorcum BV

• Part of book - Chapter (26)

  • Scholarly Publication (10)

    • A.E. Attema & W.B.F. Brouwer (2014). Constant proportional trade-offs and health state evaluations. In AC Michalos (Ed.), Encyclopedia of Quality of Life and Well-Being Research (pp. 1207-1212). Dordrecht: Springer
    • W.B.F. Brouwer (2010). Perspective, costs, outcome and discounting in pharmacoeconomic evaluations. In F.F.H. Rutten & A.G. Vulto (Eds.), PharmacoEconomics for European hospital pharmacists (pp. 12-1). Mol, Belgie: Pharma Publishing and Media Europe
    • W.B.F. Brouwer (2009). Welfare, welfarism and extra-welfarism. In M. Kattan (Ed.), Encyclopedia of medical decision making. Thousand Oaks/London/New Delhi/Singapore: Sage Publications
    • W.B.F. Brouwer & F.F.H. Rutten (2009). Cost containment and efficency in national health systems; a global comparison. In J. Rapoport, P. Jacobs & E. Jonsson (Eds.), Cost containment and efficency in national health systems; a global comparison (pp. 131-6). Weinheim: Wiley-Blackwell
    • W.B.F. Brouwer, N.J.A. van Exel & J.M. Tilford (2009). Incorporating caregiver and family effects in economic evaluation of child health. In W. Ungar (Ed.), Economic Evaluation in Child Health (pp. 55-3). Oxford: Oxford Scholarship Online Monographs
    • W.B.F. Brouwer & F.F.H. Rutten (2008). The Netherlands. In J Rapoport, P Jacobs & E Jonsson (Eds.), Cost Containment and efficiency in National Health Systems. Weinheim: Wiley-Blackwell
    • W.B.F. Brouwer, F.F.H. Rutten & M.A. Koopmanschap (2001). Costing in economic evaluations. In M. Drummond & A. McGuire (Eds.), Economic evaluation in health care; merging theory with practice (pp. 68-93). Oxford: Oxford University press
    • M.A. Koopmanschap & W.B.F. Brouwer (2001). Controversial costs in guidelines. In -- -- (Ed.), Economic evaluation; from theory to practice (pp. 129-143). --: --
    • W.B.F. Brouwer, M.A. Koopmanschap & F.F.H. Rutten (1998). Patient and informal caregiver time in cost-effectiveness analysis. A response to the recommendations of the Washington Panel. In International journal of Technology Assessment in Health Care (14, 3) (pp. 505-513). Cambridge: Cambridge University press
    • W.B.F. Brouwer & M.A. Koopmanschap (1997). Kosten binnen en buiten de gezondheidszorg. In D Post & LJ Stokx (Eds.), Volksgezondheid Toekomst Verkenning: zorgbehoefte en zorggebruik (pp. 43-56). Utrecht: ELSEVIER / De Tijdstroom

  • Professional Publication (15)

    • W.B.F. Brouwer & F.F.H. Rutten (2012). Op naar een effectieve afbakening van het basispakket: kansen en uitdagingen. In Een economische gezonde gezondszorg. Pre-adviezen Koninklijke Vereniging voor de Staatshuishoudkunde 2012 (pp. 67-87). Den Haag: Sdu uitgevers
    • N.J.A. van Exel, P.H.M. van Baal & W.B.F. Brouwer (2011). Prikkels voor gezond gedrag: een gezonde zaak? In HW van Lienden & JMD Boot (Eds.), Economie van de volksgezondheid: zorg voor gezondheid=zorg voor welvaart. Assen: van Gorcum
    • W.B.F. Brouwer & M.A. Koopmanschap (2010). Overige kosten binnen en buiten de gezondheidszorg. In M. Rutten-Van Mölken, F.F.H Rutten & C.A. Uyl-De Groot (Eds.), Van Kosten Tot Effecten Een Handleiding Voor Evaluatiestudies in De Gezondheidszorg (pp. 19-4). Maarssen: Elsevier Gezondheidszorg
    • H. Bleichrodt & W.B.F. Brouwer (2010). Disconteren. In M. Rutten-Van Mölken, F.F.H Rutten & C.A. Uyl-De Groot (Eds.), Van Kosten Tot Effecten Een Handleiding Voor Evaluatiestudies in De Gezondheidszorg (pp. 8-9). Maarssen: Elsevier Gezondheidszorg
    • F.F.H. Rutten & W.B.F. Brouwer (2007). Economische evaluaties in de gezondheidszorg. In T. Dr Ploch, R.E. Dr Juttmann, N.S. Prof.dr. Klazinga & J.P. Prof.dr Mackenbach (Eds.), Handboek gezondheidszorgonderzoek (pp. 132-10). Bohn Stafleu van Loghhum
    • J.J. Polder, P.H.M. van Baal, N.J.A. van Exel & W.B.F. Brouwer (2007). Een economisch verhaal over preventie en de waarde van gezondheid. In Jaarboek Publieke Gezondheid 2007 (pp. 128-3). Abcoude: Stichting Public Health Forum
    • J. Polder, P.H.M. van Baal, N.J.A. van Exel & W.B.F. Brouwer (2007). Preventie: niet altijd goedkoop, wel vaak een goede koop. Een economisch verhaal over preventie en de waarde van gezondheid. In Jaarboek Publieke Gezondheid (pp. 128-3). Abcoude: Stichting Public Health Forum
    • W.B.F. Brouwer & F.F.H. Rutten (2007). Zorgverzekeringen: een centraal gezondheidsonderzoeksgebied. In Handboek gezondheidszorgonderzoek (pp. 208-17). Bohn Stafleu van Loghum
    • W.B.F. Brouwer, N.J.A. van Exel & E.A. Stolk (2005). Wat heet gezond? De aanvaardbaarheid van ongezondheid op latere leeftijd. In A Wagemakers, J Ubach-Moust & L Christ (Eds.), Tijd van leven, tijd van zorgen: essays over leeftijd, levensloop, gezondheid en zorg. Utrecht: Expertisecentrum Leeftijd
    • A. de Wit & W.B.F. Brouwer (2003). Gezond gedrag als stiefkindje van economisch evaluatie onderzoek. In W. Groot, W.B.F. Brouwer & H.W. van Lienden (Eds.), Gezondheid een kapitaal goed (pp. 49-58). --: Stichting Public health forum
    • W.B.F. Brouwer (2003). Disconteren van toekomstig gezondheidskapitaal. In W. Groot, W.B.F. Brouwer & H.W. van Lienden (Eds.), Gezondheid een kapitaal goed (pp. 41-48). --: Stichting Health Forum
    • W. Groot & W.B.F. Brouwer (2003). De volksgezondheid en het volksgezondheidsbeleid. In W. Groot, W.B.F. Brouwer & H. van Lienden (Eds.), Gezondheid een kapitaal goed (pp. 9-16). --: Stichting Public Health Forum
    • W.B.F. Brouwer (2001). Europa, grensoverschrijding en patiëntenmobiliteit. In -- -- (Ed.), Handboek structuur en financiering gezondheidszorg (pp. 1-32). --: --
    • H. Bleichrodt & W.B.F. Brouwer (2000). Disconteren. In M.P.M.H. Rutten- van Mölken, J.J. van Busschbach & F.F.H. Rutten (Eds.), Van kosten tot effecten (pp. 123-130). Maarssen: Elsevier gezondheidszorg
    • W.B.F. Brouwer & M.A. Koopmanschap (2000). Overige kosten binnen en buiten de gezondheidszorg. In M.P.M.H. Rutten- van Mölken, J.J. van Busschbach & F.F.H. Rutten (Eds.), Van kosten tot effecten (pp. 43-62). Maarssen: Elsevier gezondheidszorg

  • Other Publication (1)

    • W.B.F. Brouwer & F.F.H. Rutten (2012). Health Care Rationing: Balancing Equity and Efficiency. In Health Care Rationing: Hard choices and unavoidable trade-offs (pp. 225-242). Antwerpen: Maklu Publishers

• Book editorship (2)

  • Scholarly Publication (1)

    • W.B.F. Brouwer, R. Jansen & D. Larmuseau (Ed.). (2004). Health economics adding value to healthcare. --: The Dutch Flemish Health Economic Association Anniversary Bo

  • Professional Publication (1)

    • W. Groot, W.B.F. Brouwer & H.W. van Lienden (Ed.). (2003). Gezondheid een kapitaal goed. --: Stichting Public health forum

• Book review (1)

  • F.F.H. Rutten & W.B.F. Brouwer (1997). Cost- effectiveness in health and medicine [Bespreking van het boek Cost- effectiveness in health and medicine]. .

• Report (11)

  • Scholarly Publication (2)

    • P.H.M. van Baal, N.J.A. van Exel & W.B.F. Brouwer (2015). Kosten van langer leven en de evaluatie van medische technologie. (Extern rapport, Opinion Paper 64). Tilburg: Netspar
    • P.H.M. van Baal, P. Obulqasim, W.B.F. Brouwer, W. Nusselder & J. Mackenbach (2013). The influence of health care spending on life expectancy. (Extern rapport). Tilburg: Netspar Panel Papers

  • Professional Publication (9)

    • T. Zuiderent, S. Jerak, H.M. van de Bovenkamp, S.S. Tan, L. Hakkaart-van Roijen, W.B.F. Brouwer & R.A. Bal (2011). Variatie in richtlijnen. Wat is het probleem? (Intern rapport). Rotterdam: iBMG
    • T. Zuiderent, S. Jerak, H.M. van de Bovenkamp, S.S. Tan, L. Hakkaart-van Roijen, W.B.F. Brouwer & R.A. Bal (2011). Variatie in richtlijnen. Wat is het probleem? (Extern rapport). Rotterdam: Instituut Beleid & Management Gezondheidszorg
    • E.A. Stolk & W.B.F. Brouwer (2010). Communicatie en Implementatieplan (CIP) voor het Deelprogramma HTA methodologie onder het hoofdprogramma Doelmatigheidsonderzoek Farmacotherapie. (Intern rapport). Rotterdam: IMTA
    • M. Pomp, W.B.F. Brouwer & F.T. Schut (2008). Bekostiging dure geneesmiddelen 2nd opinion NZa-voorstel bekostiging dure intramurale geneesmiddelen. (Intern rapport). onbekend: Health policy and management (BMG)
    • W.B.F. Brouwer, A.H.E. Koolman & F.F.H. Rutten (2005). Wat is productiviteitsgroei in de zorg? Een korte, conceptuele beschouwing uit economisch perspectief. (Intern rapport). onbekend: Health policy and management (BMG)
    • E.A. Stolk, M.J. Poleij, W.B.F. Brouwer & J.J. van Busschbach (2002). Proeftoetsing van het iMTA model. Identificatie van aandoeningen met minimale ziektelast en proeftoetsing van de voor ziektelast gecorrigeerde doelmatigheidstoets. (Extern rapport). Rotterdam: IMTA
    • W.B.F. Brouwer, E.K.A. van Doorslaer & H.E.G.M. Hermans (2000). Juridische en economische aspecten van Europese invloeden op wachtlijsten in de Nederlandse gezondheidszorg. (Extern rapport, ZON-VVS-200005). Den Haag: Zorgonderzoek Nederland
    • W.B.F. Brouwer, S. Ghajar, H.E.G.M. Hermans & A.H.E. Koolman (1999). Grensoverschrijdende zorg in Zeeuws-Vlaanderen Juridische en economische aspecten. (Extern rapport). Erasmus Universiteit Rotterdam: Instituut Beleid en Management Gezondheidszorg
    • W.B.F. Brouwer (1999). Het Nederlandse gezondheidszorgstelsel. (Extern rapport). Zoetermeer: Raad voor de Volksgezondheid en Zorg

• Doctoral thesis (2)

  • W.B.F. Brouwer (1999, december 3). Time and time costs in economic evaluation: taking a societal perspective. Erasmus Universiteit Rotterdam (144 pag.) (Ridderkerk: Ridderprint) Prom./coprom.: prof.dr. F.F.H. Rutten.
  • W.B.F. Brouwer (1999, december 3). Time and time costs in economic evaluation: taking a societal perspective. Erasmus Universiteit Rotterdam (171 pag.) (Ridderkerk: Ridderprint) Prom./coprom.: prof.dr. F.F.H. Rutten.

• Contribution weekly / daily journal (4)

  • W.B.F. Brouwer, M.A.J.M. Buijsen & F.F.H. Rutten (2003, juni 3). Meer zorg voor minder geld kan nog steeds. Trouw, pp. 1-1.
  • W.B.F. Brouwer & F.F.H. Rutten (2003, juli 1). Laat verzekeraars medicijnen inkopen. Trouw, pp. 1-1.
  • W.B.F. Brouwer & F.T. Schut (0099, september 10). Per ziekte een maximale wachttijd. Trouw, pp. 0-0.
  • W.B.F. Brouwer (1998, januari 12). Voorrang voor velen is vooruitgang voor velen. Trouw, pp. 1-1.

• Inaugural speech (1)

  • W.B.F. Brouwer (2009). De basis van het pakket. Oratie (2009, december 9). Rotterdam: eigen beheer

• Supervised Theses (12)

  • W.J.A. van der Deijl (2017, oktober 26). The Measurement of Wellbeing in Economics: Philosophical explorations. EUR (166 pag.) Prom./coprom.: prof.dr. J.J. Vromen, prof.dr. W.B.F. Brouwer & prof.dr. H.R. Commandeur.
  • D.R. Rappange (2016, mei 19). Future Health: A Policy and Individual Perspective. EUR Prom./coprom.: prof.dr. W.B.F. Brouwer & prof.dr. N.J.A. van Exel.
  • M. Gheorghe (2016, september 15). Quantitative Approaches in Monitoring Population Quality Of Life. EUR Prom./coprom.: prof.dr. W.B.F. Brouwer & dr. P.H.M. van Baal.
  • E.J. van de Wetering (2016, mei 12). Valuing and Refining Outcome Measures for Economic Evaluations in Health Care. EUR Prom./coprom.: prof.dr. W.B.F. Brouwer & prof.dr. N.J.A. van Exel.
  • S. Wouters (2016, september 29). Absolutely Relative : on the value of health outcomes. EUR (192 pag.) Prom./coprom.: prof.dr. W.B.F. Brouwer, prof.dr. K.I.M. Rohde & prof.dr. N.J.A. van Exel.
  • R.J. Hoefman. The impact of caregiving: the measurement and valuation of informal care for use in economic evaluations. EUR Prom./coprom.: prof.dr. W.B.F. Brouwer & prof.dr. N.J.A. van Exel.
  • M.M. Versteegh (2014, april 10). Quality of Life in Economic Evaluations of Health. EUR (187 pag.) Prom./coprom.: prof.dr. W.B.F. Brouwer.
  • P. Makai (2014, april 10). Moving Beyond The QALY: Economic evaluation in health and scoial care for elderly populations. EUR (195 pag.) Prom./coprom.: prof.dr. W.B.F. Brouwer & prof.dr. A.P. Nieboer.[go to publisher's site]
  • L.M. Niëns (2014, januari 10). Affordability in Health Care: Operationalizatoins and applications in different contexts. EUR (192 pag.) (Rotterdam) Prom./coprom.: prof.dr. W.B.F. Brouwer & prof.dr. F.F.H. Rutten.
  • H.M. Krol (2012, december 21). Productivity costs in economic evaluations. EUR (268 pag.) (Rotterdam: Optima Grafische Communicatie) Prom./coprom.: prof.dr. W.B.F. Brouwer.
  • A. Bobinac (2012, mei 11). Economic evaluations of health technologies: Insights into the measurement and valuation of benefits. EUR (227 pag.) (Rotterdam: Optima Grafische Communicatie Rotterdam) Prom./coprom.: prof.dr. W.B.F. Brouwer, prof.dr. F.F.H. Rutten & N.J.A Exel van.
  • E. Erdogan Ciftci (2012, september 28). Health perceptions and labour force participation of older workers. Erasmus University Rotterdam (172 pag.) (Rotterdam: Tinbergen Institute) Prom./coprom.: prof.dr. E.K.A. van Doorslaer, Prof.Dr. A. Lopez-Nicolas, dr. T.M. Bago d'Uva, prof.dr. O.A. O'Donnell, M. Lindeboom & prof.dr. W.B.F. Brouwer.

Ancillary activities (9)

Editorial positions (4)

Present position

Other positions (1)